Induction Therapy with Basiliximab Allows Delayed Initiation of Cyclosporine and Preserves Renal Function After Cardiac Transplantation

Basiliximab induction therapy allows delayed initiation of cyclosporine after cardiac transplantation without an increase in rejection and reduces the risk of post-operative renal dysfunction.